Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention-Reference-Cited by-同舟云学术

Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention

Published:2011-04-28 Issue:3 Volume:27 Page:243-249
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Chen Yundai,Wang Changhua,Yang Xinchun,Wang Lefeng,Sun Zhijun,Liu Hongbin,Chen Lian

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-011-0144-2.pdf

Reference28 articles.

1. Pepine CJ (2004) Ischemic heart disease in women: facts and wishful thinking. J Am Coll Cardiol 43:1727–1730

2. Lee KH, Jeong MH, Ahn YK, Kim JH, Chae SC, Kim YJ, Hur SH, Seong IW, Hong TJ, Choi D, Cho MC, Kim CJ, Seung KB, Chung WS, Jang YS, Cho JG, Park SJ, Korea Acute Myocardial Infarction Registry (KAMIR) Investigators (2008) Gender differences of success rate of percutaneous coronary intervention and short-term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 130:227–234

3. Vaknin-Assa H, Assali A, Fuchs S, Zafrir N, Kornowski R (2006) Prognostic impact of sex on clinical outcomes following emergent coronary angioplasty in acute myocardial infarction. Coron Artery Dis 17:1–5

4. De Luca G, Suryapranata H, Dambrink JH, Ottervanger JP, Van’t Hof AW, Zijlstra F, Hoorntje JC, Gosselink AT, de Boer MJ (2004) Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study. Am Heart J 148:852–856

5. Lansky AJ, Pietras C, Costa RA, Tsuchiya Y, Brodie BR, Cox DA, Aymong ED, Stuckey TD, Garcia E, Tcheng JE, Mehran R, Negoita M, Fahy M, Cristea E, Turco M, Leon MB, Grines CL, Stone GW (2005) Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. Circulation 111:1611–1618

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalencia e implicaciones pronósticas del fenómeno de no reflujo en pacientes sometidos a intervencionismo coronario percutáneo primario en un centro universitario de un país de ingresos medios;Archivos de Cardiología de México;2024-07-17

2. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score;Circulation: Cardiovascular Interventions;2024-04

3. Association of Pre-PCI Blood Pressure and No-Reflow in Patients with Acute ST-Elevation Coronary Infarction;Global Heart;2024-03-04

4. Association between DBP and major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention;Journal of Hypertension;2021-12-09

5. A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction;Annals of Translational Medicine;2021-01